EXTON, Pa., Aug. 30, 2011 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the following investor conferences in September.
Kensey Nash will be participating at the Barrington Research Growth Conference 2011 in Chicago on Wednesday, September 7th, 2011. The presentation materials will be available on the company’s website (www.kenseynash.com) at 8:00 a.m. ET on Wednesday, September 7th, 2011.
Michael Celano, Kensey Nash’s Chief Financial Officer, will deliver the Company’s presentation, at the CL King’s 9th Annual Best Ideas Conference at the Omni Berkshire Place Hotel in New York on Tuesday, September 13th, 2011 at 3:45 p.m. (ET). To hear the live webcast of the Kensey Nash presentation, go to http://www.videonewswire.com/event.asp?id=81468. The webcast will be archived for ninety days following the live presentation. The presentation materials will also be available on the company’s website (www.kenseynash.com) beginning at 3:45 p.m. (ET) on Tuesday, September 13th, 2011.
Joseph W. Kaufmann, Kensey Nash’s President & CEO, will deliver the Company’s presentation, at the UBS Global Life Sciences Conference at the Grand Hyatt Hotel in New York on Wednesday, September 21st, 2011 beginning at approximately at 9:00 a.m. (ET). The presentation materials will also be available on the company’s website (www.kenseynash.com) beginning at 9:00 a.m. (ET) on Wednesday, September 21st, 2011.
Joseph W. Kaufmann will deliver the Company’s presentation at the Jefferies 2011 Global Healthcare Conference in London on Tuesday, September 27th, 2011 beginning approximately at 10:00 p.m. (ET). To hear the live webcast of the Kensey Nash presentation, go to http://www.wsw.com/webcast/jeff62/knsy/. The webcast will be archived for ninety days following the live presentation. The presentation materials will also be available on the company’s website (www.kenseynash.com) beginning at 10:00 p.m. (ET) on Tuesday, September 27th, 2011.
About Kensey Nash Corporation. Kensey Nash Corporation is a medical device company primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology. The Company is recognized as a leader for innovative product development and unique technology in the field of resorbable biomaterials. The Company has an extensive range of products, which are sold through strategic partners in multiple medical markets, including the cardiology, orthopaedic, sports medicine, spine, endovascular and general surgery markets. For more information, visit www.kenseynash.com.
SOURCE Kensey Nash Corporation
